Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency

Por van Geffen, M, Cugno, M, Lap, P, Loof, A, Cicardi, M, van Heerde, W
Publicado em 2012

Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation.

Por van Heerde, W L, Poort, S, van 't Veer, C, Reutelingsperger, C P, de Groot, P G
Publicado em 1994

Proteomic analysis of Systemic Sclerosis serum identifies the toll-like receptor agonists S100A8/A9 as a novel possible pathogenic marker

Por van Bon, L, Loof, A, Wittkowski, H, van Heerde, W, Vonk, M, Roth, J, van den Berg, W, van Lent, P, Radstake, TRDJ
Publicado em 2010

Annexin A5 polymorphism (−1C→T) and the presence of anti‐annexin A5 antibodies in the antiphospholipid syndrome

Por de Laat, B, Derksen, R H W M, Mackie, I J, Roest, M, Schoormans, S, Woodhams, B J, de Groot, P G, van Heerde, W L
Publicado em 2006

Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

Por van Bon, L., Affandi, A.J., Broen, J., Christmann, R.B., Marijnissen, R.J., Stawski, L., Farina, G.A., Stifano, G., Mathes, A.L., Cossu, M., York, M., Collins, C., Wenink, M., Huijbens, R., Hesselstrand, R., Saxne, T., DiMarzio, M., Wuttge, D., Agarwal, S.K., Reveille, J.D., Assassi, S., Mayes, M., Deng, Y., Drenth, J.P.H., de Graaf, J., den Heijer, M., Kallenberg, C.G.M., Bijl, M., Loof, A., van den Berg, W.B., Joosten, L.A.B., Smith, V., de Keyser, F., Scorza, R., Lunardi, C., van Riel, P.L.C.M., Vonk, M., van Heerde, W., Meller, S., Homey, B., Beretta, L., Roest, M., Trojanowska, M., Lafyatis, R., Radstake, T.R.D.J.
Publicado em 2013